HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Platelet-derived growth factor-stimulated versican synthesis but not glycosaminoglycan elongation in vascular smooth muscle is mediated via Akt phosphorylation.

Abstract
Proteoglycans are associated with the initiation of atherosclerosis due to their binding of apolipoproteins on lipid particles leading to retention in the vessel wall. The signaling pathways through which growth factors regulate the synthesis and structure of proteoglycans are potential therapeutic targets. Platelet-derived growth factor (PDGF) is present in atherosclerotic plaques and activates phosphorylation of the serine/threonine kinase Akt. We have investigated the role of Akt in the signaling pathways for proteoglycan core protein expression and elongation of glycosaminoglycan chains on proteoglycans secreted by human vascular smooth muscle cells. The pharmacological inhibitor of Akt phosphorylation, SN30978, blocked PDGF stimulated phosphorylation of Akt. SN30978 caused concentration dependent inhibition of PDGF stimulated radiosulfate incorporation into secreted proteoglycans and the response was blocked by the PDGF receptor antagonists Ki11502 and imatinib. Analysis of the size of the biglycan molecules by SDS-PAGE showed that PDGF increased the apparent size of biglycan but this effect on glycosaminoglycan chain elongation was blocked by Ki11502 but not by SN30978. PDGF also stimulated total protein core protein synthesis assessed as (35)S-methionine/cysteine incorporation and specifically the expression of versican mRNA. Both of these responses were blocked by SN30978. This data shows that PDGF-stimulated proteoglycan core protein synthesis but not glycosaminoglycan chain elongation is mediated via Akt phosphorylation. These data identify potential pathways for the development of agents which can pharmacologically regulate individual components of the synthesis of proteoglycans.
AuthorsNarin Osman, Robel Getachew, Lyna Thach, Haitao Wang, Xiaoying Su, Wenhua Zheng, Peter J Little
JournalCellular signalling (Cell Signal) Vol. 26 Issue 5 Pg. 912-6 (May 2014) ISSN: 1873-3913 [Electronic] England
PMID24462709 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Benzamides
  • Glycosaminoglycans
  • Ki11502
  • Piperazines
  • Platelet-Derived Growth Factor
  • Pyrimidines
  • Quinolines
  • RNA, Messenger
  • Versicans
  • Imatinib Mesylate
  • Receptors, Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-akt
Topics
  • Benzamides (pharmacology)
  • Cells, Cultured
  • Glycosaminoglycans (metabolism)
  • Humans
  • Imatinib Mesylate
  • Muscle, Smooth, Vascular (cytology, drug effects, metabolism)
  • Phosphorylation (drug effects)
  • Piperazines (pharmacology)
  • Platelet-Derived Growth Factor (pharmacology)
  • Protein Biosynthesis (drug effects)
  • Proto-Oncogene Proteins c-akt (antagonists & inhibitors, metabolism)
  • Pyrimidines (pharmacology)
  • Quinolines (pharmacology)
  • RNA, Messenger (metabolism)
  • Receptors, Platelet-Derived Growth Factor (antagonists & inhibitors, metabolism)
  • Versicans (biosynthesis, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: